Browsing: Secondary Life Markets
Longevity and Mortality Investor’s coverage of the secondary life markets, including life settlements, equity release, reverse mortgages and life contingent structured settlements.
£83m full scheme bulk purchase annuity buy-in secures the benefits of all 468 scheme members.
Life settlement market continuing growth trajectory despite overall reduction in life settlement provider licenses.
Updating the life expectancy of an insured throughout the life of a life settlement investment plays a critical role in best practice life settlement portfolio management.
Daniel will build upon CCA’s capabilities in leveraging data and advanced machine learning tools to assess and mitigate risk when buying and holding policies.
Latest Fact Sheet includes the annual update to ELSA’s Licensed Provider Matrix, which provides details on the number of licensed life settlement providers, and the states and territories in which they hold a license.
According to the latest data from the Equity Release Council, total lending increased to £597m during Q2 2026, up 4% on the previous quarter (£574m).
A recent decision by the Delaware Court of Chancery brings some clarity to life settlement investors regarding the statute of limitations in the state. Greg Winterton provides a summary overview of the details.
Decision is a significant positive development for investors in the life settlement industry as it reinforces the enforceability of premium-financed policies where statutory insurable interest requirements are met at inception.
General pace of activity picking up after slow first quarter of 2026.
Complexity in modelling cash flows and risks in longevity-linked assets means challenges for asset managers looking to source capital from US insurers.